[{"id":"fb51302a-0bd4-449d-a782-2467f960811a","acronym":"","url":"https://clinicaltrials.gov/study/NCT01870596","created_at":"2021-01-18T08:22:32.855Z","updated_at":"2024-07-02T16:37:29.374Z","phase":"Phase 2","brief_title":"Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia","source_id_and_acronym":"NCT01870596","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" CYP1A2","pipe":"","alterations":" ","tags":["CYP1A2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cytarabine • MK-8776"],"overall_status":"Completed","enrollment":" Enrollment 32","initiation":"Initiation: 05/01/2013","start_date":" 05/01/2013","primary_txt":" Primary completion: 12/01/2014","primary_completion_date":" 12/01/2014","study_txt":" Completion: 12/01/2014","study_completion_date":" 12/01/2014","last_update_posted":"2016-09-01"}]